Review




Structured Review

Meso Scale Diagnostics LLC multiplex protein arrays
Multiplex Protein Arrays, supplied by Meso Scale Diagnostics LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multiplex+protein+array+technology/multiplex+protein+array+plates/pm39198925-81-39-45
Average 90 stars, based on 1 article reviews
multiplex protein arrays - by Bioz Stars, 2026-11
90/100 stars

Images

Related Articles

Clinical Proteomics:

Article Title: A Phase II and Biomarker Study of Sorafenib Combined with Modified FOLFOX in Patients with Advanced Hepatocellular Carcinoma (HCC)
Article Snippet: .. Plasma analysis was carried out for a panel of circulating pro-angiogenic and pro-inflammatory biomarkers: VEGF, placental growth factor (PlGF), soluble (s)VEGFR1/FLT-1, basic fibroblast growth factor (bFGF), VEGF-C, VEGF-D, sTIE-2, interleukin (IL)-1β, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12p70, interferon (IFN)-α, and tumor necrosis factor (TNF)-α using multiplex protein array plates from Meso-Scale Discovery (Gaithersburg, MD); and carbonic anhydrase (CA)IX, sVEGFR2, s-c-KIT and sMET using ELISA kits from R&D Systems (Minneapolis, MN) and Life Technologies/Invitrogen (Carlsbad, CA), respectively. ..

Article Title: A Phase II and Biomarker Study of Sorafenib Combined with Modified FOLFOX in Patients with Advanced Hepatocellular Carcinoma
Article Snippet: .. Plasma analysis was carried out for a panel of circulating pro-angiogenic and proinflammatory biomarkers: VEGF, placental growth factor (PlGF), soluble (s)VEGFR1/FLT-1, basic fibroblast growth factor (bFGF), VEGF-C, VEGF-D, sTIE-2, interleukin (IL)-1, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12p70, interferon (IFN)-α, and tumor necrosis factor (TNF)-α using multiplex protein array plates from Meso-Scale Discovery (Gaithersburg, MD); and carbonic anhydrase (CA)IX, sVEGFR2, s-c-KIT and sMET using ELISA kits from R&D Systems (Minneapolis, MN) and Life Technologies/Invitrogen (Carlsbad, CA), respectively. ..

Article Title: A Phase II and Biomarker Study of Cabozantinib in Patients with Advanced Cholangiocarcinoma
Article Snippet: .. Plasma analysis was carried out for a panel of circulating pro-angiogenic and pro-inflammatory biomarkers: VEGF, placental growth factor (PlGF), soluble (s)VEGFR1/FLT-1, basic fibroblast growth factor (bFGF), VEGF-C, VEGF-D, TIE-2, interleukin (IL)-1β, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12p70, interferon (IFN)-γ, and tumor necrosis factor (TNF)-α using multiplex protein array plates from Meso-Scale Discovery (Gaithersburg, MD); and HGF, sVEGFR2, angiopoietin-1 (Ang-1), Ang-2, tissue inhibitor on matrix metalloproteinase (TIMP)-1, carbonic anhydrase (CA)-IX, free insulin-like growth factor (IGF)-I and stromal-derived factor (SDF1)-α from R&D Systems (Minneapolis, MN), and sMet from Life Technologies/Invitrogen (Carlsbad, CA). ..

Multiplex Assay:

Article Title: A Phase II and Biomarker Study of Sorafenib Combined with Modified FOLFOX in Patients with Advanced Hepatocellular Carcinoma (HCC)
Article Snippet: .. Plasma analysis was carried out for a panel of circulating pro-angiogenic and pro-inflammatory biomarkers: VEGF, placental growth factor (PlGF), soluble (s)VEGFR1/FLT-1, basic fibroblast growth factor (bFGF), VEGF-C, VEGF-D, sTIE-2, interleukin (IL)-1β, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12p70, interferon (IFN)-α, and tumor necrosis factor (TNF)-α using multiplex protein array plates from Meso-Scale Discovery (Gaithersburg, MD); and carbonic anhydrase (CA)IX, sVEGFR2, s-c-KIT and sMET using ELISA kits from R&D Systems (Minneapolis, MN) and Life Technologies/Invitrogen (Carlsbad, CA), respectively. ..

Article Title: Systemic inflammation following traumatic injury and its impact on neuroinflammatory gene expression in the rodent brain
Article Snippet: .. Serum interleukin-beta (IL-β), interleukin-6 (IL-6), chemokine (C-X-C motif) ligand 1 (CXCL1), tumor necrosis factor alpha (TNF-α), monocyte chemoattractant protein-1 (MCP-1; CCL2) and interferon gamma (IFN-γ) levels were assayed at 1, 3, 6, 24, 72, and 168 hpi using multiplex protein arrays (n = 5–7/group; Meso Scale Diagnostics, Rockville, Maryland, USA). ..

Article Title: Cutaneous burn injury represents a major risk factor for the development of traumatic ectopic bone formation following blast-related extremity injury.
Article Snippet: Blast-related traumatic heterotopic ossification (tHO) impacts clinical outcomes in combat-injured patients, leading to delayed wound healing, inflammatory complications, and reduced quality of life.. Blast injured patients often have significant burns.. This study investigated whether a partial thickness thermal burn injury exacerbates blast-related tHO in a clinically relevant polytrauma animal model.

Article Title: A Phase II and Biomarker Study of Sorafenib Combined with Modified FOLFOX in Patients with Advanced Hepatocellular Carcinoma
Article Snippet: .. Plasma analysis was carried out for a panel of circulating pro-angiogenic and proinflammatory biomarkers: VEGF, placental growth factor (PlGF), soluble (s)VEGFR1/FLT-1, basic fibroblast growth factor (bFGF), VEGF-C, VEGF-D, sTIE-2, interleukin (IL)-1, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12p70, interferon (IFN)-α, and tumor necrosis factor (TNF)-α using multiplex protein array plates from Meso-Scale Discovery (Gaithersburg, MD); and carbonic anhydrase (CA)IX, sVEGFR2, s-c-KIT and sMET using ELISA kits from R&D Systems (Minneapolis, MN) and Life Technologies/Invitrogen (Carlsbad, CA), respectively. ..

Article Title: Systemic inflammation following traumatic injury and its impact on neuroinflammatory gene expression in the rodent brain.
Article Snippet: .. Serum interleukin-beta (IL-β), interleukin-6 (IL-6), chemokine (C-X-C motif ) ligand 1 (CXCL1), tumor necrosis factor alpha (TNF-α), monocyte chemoattractant protein-1 (MCP-1; CCL2) and interferon gamma (IFN-γ) levels were assayed at 1, 3, 6, 24, 72, and 168 hpi using multiplex protein arrays (n = 5–7/group; Meso Scale Diagnostics, Rockville, Maryland, USA). ..

Article Title: A Phase II and Biomarker Study of Cabozantinib in Patients with Advanced Cholangiocarcinoma
Article Snippet: .. Plasma analysis was carried out for a panel of circulating pro-angiogenic and pro-inflammatory biomarkers: VEGF, placental growth factor (PlGF), soluble (s)VEGFR1/FLT-1, basic fibroblast growth factor (bFGF), VEGF-C, VEGF-D, TIE-2, interleukin (IL)-1β, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12p70, interferon (IFN)-γ, and tumor necrosis factor (TNF)-α using multiplex protein array plates from Meso-Scale Discovery (Gaithersburg, MD); and HGF, sVEGFR2, angiopoietin-1 (Ang-1), Ang-2, tissue inhibitor on matrix metalloproteinase (TIMP)-1, carbonic anhydrase (CA)-IX, free insulin-like growth factor (IGF)-I and stromal-derived factor (SDF1)-α from R&D Systems (Minneapolis, MN), and sMet from Life Technologies/Invitrogen (Carlsbad, CA). ..

Protein Array:

Article Title: A Phase II and Biomarker Study of Sorafenib Combined with Modified FOLFOX in Patients with Advanced Hepatocellular Carcinoma (HCC)
Article Snippet: .. Plasma analysis was carried out for a panel of circulating pro-angiogenic and pro-inflammatory biomarkers: VEGF, placental growth factor (PlGF), soluble (s)VEGFR1/FLT-1, basic fibroblast growth factor (bFGF), VEGF-C, VEGF-D, sTIE-2, interleukin (IL)-1β, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12p70, interferon (IFN)-α, and tumor necrosis factor (TNF)-α using multiplex protein array plates from Meso-Scale Discovery (Gaithersburg, MD); and carbonic anhydrase (CA)IX, sVEGFR2, s-c-KIT and sMET using ELISA kits from R&D Systems (Minneapolis, MN) and Life Technologies/Invitrogen (Carlsbad, CA), respectively. ..

Article Title: A Phase II and Biomarker Study of Sorafenib Combined with Modified FOLFOX in Patients with Advanced Hepatocellular Carcinoma
Article Snippet: .. Plasma analysis was carried out for a panel of circulating pro-angiogenic and proinflammatory biomarkers: VEGF, placental growth factor (PlGF), soluble (s)VEGFR1/FLT-1, basic fibroblast growth factor (bFGF), VEGF-C, VEGF-D, sTIE-2, interleukin (IL)-1, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12p70, interferon (IFN)-α, and tumor necrosis factor (TNF)-α using multiplex protein array plates from Meso-Scale Discovery (Gaithersburg, MD); and carbonic anhydrase (CA)IX, sVEGFR2, s-c-KIT and sMET using ELISA kits from R&D Systems (Minneapolis, MN) and Life Technologies/Invitrogen (Carlsbad, CA), respectively. ..

Article Title: PEARL: A Phase Ib/II Biomarker Study of Adding Radiation Therapy to Pembrolizumab Before Neoadjuvant Chemotherapy in Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer
Article Snippet: PURPOSE To assess safety and immune biomarkers after preoperative radiation therapy (RT) and anti-PD1 therapy in breast cancer.. MATERIALS AND METHODS Aphase I/IIb trial of pembrolizumabwithRTwas conducted inpatientswith triplenegative breast cancer (TNBC) and hormone receptor–positive/human epidermal growth factor receptor 2–negative (HR1/HER2–) breast cancer.. All received pembrolizumab followed by a second cycle 1 RT (anti-PD1/RT) of 24 Gy/three daily fractions delivered to the breast tumor and then neoadjuvant chemotherapy (NAC).

Article Title: A Phase II and Biomarker Study of Cabozantinib in Patients with Advanced Cholangiocarcinoma
Article Snippet: .. Plasma analysis was carried out for a panel of circulating pro-angiogenic and pro-inflammatory biomarkers: VEGF, placental growth factor (PlGF), soluble (s)VEGFR1/FLT-1, basic fibroblast growth factor (bFGF), VEGF-C, VEGF-D, TIE-2, interleukin (IL)-1β, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12p70, interferon (IFN)-γ, and tumor necrosis factor (TNF)-α using multiplex protein array plates from Meso-Scale Discovery (Gaithersburg, MD); and HGF, sVEGFR2, angiopoietin-1 (Ang-1), Ang-2, tissue inhibitor on matrix metalloproteinase (TIMP)-1, carbonic anhydrase (CA)-IX, free insulin-like growth factor (IGF)-I and stromal-derived factor (SDF1)-α from R&D Systems (Minneapolis, MN), and sMet from Life Technologies/Invitrogen (Carlsbad, CA). ..

Enzyme-linked Immunosorbent Assay:

Article Title: A Phase II and Biomarker Study of Sorafenib Combined with Modified FOLFOX in Patients with Advanced Hepatocellular Carcinoma (HCC)
Article Snippet: .. Plasma analysis was carried out for a panel of circulating pro-angiogenic and pro-inflammatory biomarkers: VEGF, placental growth factor (PlGF), soluble (s)VEGFR1/FLT-1, basic fibroblast growth factor (bFGF), VEGF-C, VEGF-D, sTIE-2, interleukin (IL)-1β, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12p70, interferon (IFN)-α, and tumor necrosis factor (TNF)-α using multiplex protein array plates from Meso-Scale Discovery (Gaithersburg, MD); and carbonic anhydrase (CA)IX, sVEGFR2, s-c-KIT and sMET using ELISA kits from R&D Systems (Minneapolis, MN) and Life Technologies/Invitrogen (Carlsbad, CA), respectively. ..

Article Title: A Phase II and Biomarker Study of Sorafenib Combined with Modified FOLFOX in Patients with Advanced Hepatocellular Carcinoma
Article Snippet: .. Plasma analysis was carried out for a panel of circulating pro-angiogenic and proinflammatory biomarkers: VEGF, placental growth factor (PlGF), soluble (s)VEGFR1/FLT-1, basic fibroblast growth factor (bFGF), VEGF-C, VEGF-D, sTIE-2, interleukin (IL)-1, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12p70, interferon (IFN)-α, and tumor necrosis factor (TNF)-α using multiplex protein array plates from Meso-Scale Discovery (Gaithersburg, MD); and carbonic anhydrase (CA)IX, sVEGFR2, s-c-KIT and sMET using ELISA kits from R&D Systems (Minneapolis, MN) and Life Technologies/Invitrogen (Carlsbad, CA), respectively. ..

Analysis:

Article Title: A Phase II and Biomarker Study of Cabozantinib in Patients with Advanced Cholangiocarcinoma
Article Snippet: .. Plasma analysis was carried out for a panel of circulating pro-angiogenic and pro-inflammatory biomarkers: VEGF, placental growth factor (PlGF), soluble (s)VEGFR1/FLT-1, basic fibroblast growth factor (bFGF), VEGF-C, VEGF-D, TIE-2, interleukin (IL)-1β, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12p70, interferon (IFN)-γ, and tumor necrosis factor (TNF)-α using multiplex protein array plates from Meso-Scale Discovery (Gaithersburg, MD); and HGF, sVEGFR2, angiopoietin-1 (Ang-1), Ang-2, tissue inhibitor on matrix metalloproteinase (TIMP)-1, carbonic anhydrase (CA)-IX, free insulin-like growth factor (IGF)-I and stromal-derived factor (SDF1)-α from R&D Systems (Minneapolis, MN), and sMet from Life Technologies/Invitrogen (Carlsbad, CA). ..

Tissue:

Article Title: A Phase II and Biomarker Study of Cabozantinib in Patients with Advanced Cholangiocarcinoma
Article Snippet: .. Plasma analysis was carried out for a panel of circulating pro-angiogenic and pro-inflammatory biomarkers: VEGF, placental growth factor (PlGF), soluble (s)VEGFR1/FLT-1, basic fibroblast growth factor (bFGF), VEGF-C, VEGF-D, TIE-2, interleukin (IL)-1β, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12p70, interferon (IFN)-γ, and tumor necrosis factor (TNF)-α using multiplex protein array plates from Meso-Scale Discovery (Gaithersburg, MD); and HGF, sVEGFR2, angiopoietin-1 (Ang-1), Ang-2, tissue inhibitor on matrix metalloproteinase (TIMP)-1, carbonic anhydrase (CA)-IX, free insulin-like growth factor (IGF)-I and stromal-derived factor (SDF1)-α from R&D Systems (Minneapolis, MN), and sMet from Life Technologies/Invitrogen (Carlsbad, CA). ..



Similar Products

86
DiaSorin Biotechnology multiplex protein array technology
Multiplex Protein Array Technology, supplied by DiaSorin Biotechnology, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multiplex+protein+array+technology/pmc04304418-12-31-35
Average 86 stars, based on 1 article reviews
multiplex protein array technology - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

92
Bio-Rad multiplex protein array system technology
Multiplex Protein Array System Technology, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multiplex+protein+array+technology/ProteOn+Multiple+Protein+Interaction+Kit/10__1158_slash_0008___5472__can___09___1627-65-5-10
Average 92 stars, based on 1 article reviews
multiplex protein array system technology - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

Image Search Results